Shandong Wohua Pharmaceutical Co., Ltd.
002107.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.24B
Close$
$4.79
28.4% downside
Current Fair Value
28.4% downsideOvervalued by 28.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.24 Billion |
|---|---|
| Enterprise Value | $3.86 Billion |
| Dividend Yield | $0.24 (5.21%) |
| Earnings per Share | $0.17 |
| Beta | 0.31 |
| Outstanding Shares | 577,209,600 |
Return
| Return on Equity | 16.77% |
|---|---|
| Return on Assets | 12.41% |
| Return on Invested Capital | 18.82% |
Valuation & Multiples
| P/E Ratio | 35.52 |
|---|---|
| PEG | 85.16 |
| Price to Sales | 6.69 |
| Price to Book Ratio | 6.69 |
| Enterprise Value to Revenue | 4.92 |
| Enterprise Value to EBIT | 28.55 |
| Enterprise Value to Net Income | 32 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 15, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Shandong Wohua Pharmaceutical Co., Ltd.
1,018 employees
CEO: Shengting Li Shandong Wohua Pharmaceutical Co., Ltd. is a Chinese enterprise engaged in the development, production, and distribution of a broad array of medicinal products across the country. The company's extensive product portfolio addresses vario...